Navigation Links
NOVAVAX to Present at BIO Investor Forum
Date:9/29/2010

ROCKVILLE, Md., Sept. 29 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage biopharmaceutical company, announced today that Mr. Frederick Driscoll, Chief Financial Officer of Novavax, will be presenting at the BIO Investor Forum. The presentation will take place on Wednesday, October 6, 2010 at 1:00pm PT at the Palace Hotel, San Francisco, California. Mr. Driscoll will provide a company overview, outline its competitive position and characterize Novavax's outlook.

About Novavax

Novavax, Inc. is a clinical-stage biopharmaceutical company creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like-particle (VLP) technology. The company produces potent VLP-based recombinant vaccines utilizing new and efficient manufacturing approaches. Novavax is committed to using its VLP technology to create country-specific vaccine solutions. The company has formed a joint venture with Cadila Pharmaceuticals, named CPL Biologicals, to develop and manufacture vaccines, biological therapeutics and diagnostics in India. Additional information about Novavax is available on the company's website: www.novavax.com.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. NOVAVAX to Present at Stifel Nicolaus Conference
2. NOVAVAX Endorses New U.S. Initiatives to Develop Medical Countermeasures
3. NOVAVAX Announces Issuance of Key U.S. Patent for Influenza Virus-Like Particle (VLP) Vaccines
4. Novavax CEO to Present at Phacilitate Vaccine Forum Barcelona 2010
5. Novavaxs Seasonal Influenza VLP Vaccine Candidate Shows Positive Results in a Phase II Clinical Trial in Older Adults
6. NOVAVAX Reports Fourth Quarter and 2009 Year-End Financial Results
7. NOVAVAX to Present at 22nd Annual ROTH OC Growth Stock Conference
8. NOVAVAX to Present at Cowen and Companys 30th Annual Health Care Conference
9. NOVAVAX Reports Additional Positive Data from Its Trivalent Seasonal Influenza (VLP) Vaccine Clinical Study in Healthy Adults
10. Novavax Terminates Negotiations with ROVI Pharmaceuticals for Influenza Vaccine Collaboration
11. NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... 2016 The global  non-invasive prenatal testing market  is ... report by Grand View Research, Inc. Evolution of prenatal testing in the ... serum screening and invasive diagnostic testing to determine the likelihood of fetal ... the forecast period. Continue Reading ... ...
(Date:12/4/2016)... Blueprint Medicines Corporation (NASDAQ: BPMC ... kinase medicines for patients with genomically defined diseases, ... trial evaluating BLU-285, an investigational medicine for the ... Blueprint Medicines is developing BLU-285 as a potent, ... 90 to 95 percent of patients with SM ...
(Date:12/4/2016)... , Dec. 2, 2016  Former Attorney General of ... , a partner at the law firm of Kahn Swick ... investigation into Lannett Company, Inc. (NYSE: LCI ). ... published an article titled "U.S. Charges in Generic-Drug Probe to ... by the Justice Department, begun about two years ago, now ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... December 05, 2016 , ... A newly ... significantly improves the reproducibility and accuracy of placing precordial electrodes with little cognitive ... Over the last 60 years, studies have shown that single electrode misplacement is ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... "Best Surgical Body Shaping" at the 2016 Anti-Aging & Beauty Awards ... , The Aesthetic & Anti-Aging Medicine European Congress (AMEC) brings together ...
(Date:12/4/2016)... ... 2016 , ... Responsible dental care hinges on regular brushing of the teeth. ... This important necessity inspired an inventor from Las Vegas, Nev., to design the BRUSH ... break or avoid bad techniques of brushing the teeth in order to prevent cavities," ...
(Date:12/2/2016)... ... , ... For over twenty-four years, Doctors on Liens has published a directory of ... quality medical care. When the company started in 1997, the directory was a single ... and the now ten-page directory features a vast array of medical specialists stretching ...
(Date:12/2/2016)... Raleigh, NC (PRWEB) , ... December 02, 2016 , ... ... the Open Enrollment Period (or Annual Election Period), is ending December 7th. Currently-enrolled Medicare ... plan (Part C) or prescription drug plan (Part D) need to make changes during ...
Breaking Medicine News(10 mins):